Wells Fargo’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Buy |
364,205
+108,520
| +42% | +$4.75M | ﹤0.01% | 1612 |
|
|
2025
Q4 | $9.88M | Buy |
255,685
+35,422
| +16% | +$1.35M | ﹤0.01% | 2054 |
|
|
2025
Q3 | $7.77M | Buy |
220,263
+144,475
| +191% | +$5.23M | ﹤0.01% | 2205 |
|
|
2025
Q2 | $2.73M | Sell |
75,788
-8,486
| -10% | -$281K | ﹤0.01% | 2956 |
|
|
2025
Q1 | $2.62M | Buy |
84,274
+14,154
| +20% | +$449K | ﹤0.01% | 2948 |
|
|
2024
Q4 | $1.79M | Buy |
70,120
+15,790
| +29% | +$419K | ﹤0.01% | 3275 |
|
|
2024
Q3 | $1.54M | Buy |
54,330
+6,174
| +13% | +$171K | ﹤0.01% | 3245 |
|
|
2024
Q2 | $1.27M | Sell |
48,156
-2,189
| -4% | -$60.7K | ﹤0.01% | 3331 |
|
|
2024
Q1 | $1.53M | Buy |
50,345
+35,453
| +238% | +$1.05M | ﹤0.01% | 3175 |
|
|
2023
Q4 | $418K | Buy |
14,892
+311
| +2% | +$8.55K | ﹤0.01% | 3979 |
|
|
2023
Q3 | $396K | Sell |
14,581
-28,820
| -66% | -$856K | ﹤0.01% | 3925 |
|
|
2023
Q2 | $1.33M | Buy |
43,401
+8,202
| +23% | +$278K | ﹤0.01% | 3229 |
|
|
2023
Q1 | $1.27M | Buy |
35,199
+12,571
| +56% | +$466K | ﹤0.01% | 3212 |
|
|
2022
Q4 | $894K | Sell |
22,628
-16,170
| -42% | -$675K | ﹤0.01% | 3310 |
|
|
2022
Q3 | $1.56M | Buy |
38,798
+3,642
| +10% | +$156K | ﹤0.01% | 2917 |
|
|
2022
Q2 | $1.48M | Buy |
35,156
+7,547
| +27% | +$309K | ﹤0.01% | 3024 |
|
|
2022
Q1 | $1.08M | Buy |
27,609
+3,543
| +15% | +$139K | ﹤0.01% | 3827 |
|
|
2021
Q4 | $959K | Sell |
24,066
-32,848
| -58% | -$1.28M | ﹤0.01% | 4146 |
|
|
2021
Q3 | $2.06M | Sell |
56,914
-49,210
| -46% | -$1.91M | ﹤0.01% | 3651 |
|
|
2021
Q2 | $4.35M | Buy |
106,124
+70,277
| +196% | +$2.99M | ﹤0.01% | 2985 |
|
|
2021
Q1 | $1.56M | Sell |
35,847
-350,796
| -91% | -$16.6M | ﹤0.01% | 3914 |
|
|
2020
Q4 | $19.4M | Buy |
386,643
+357,244
| +1,215% | +$15.2M | ﹤0.01% | 1586 |
|
|
2020
Q3 | $1.24M | Sell |
29,399
-336,931
| -92% | -$14.5M | ﹤0.01% | 3687 |
|
|
2020
Q2 | $17.8M | Buy |
+366,330
| New | +$18.1M | 0.01% | 1442 |
|